Table 1 Analysis of patient demographics and laboratory parameters by prognosis.
From: Predictive value of PD-1+CD3+ T cells for 30-day mortality in patients with sepsis
Parameters | Total (n = 180) | Survivors (n = 117) | Non-survivors (n = 63) | P |
|---|---|---|---|---|
Age, median(IQR) years | 71.00 (57.75, 79.25) | 69.00 (51.00, 78.00) | 74.00 (66.50, 81.50) | 0.001 |
Gender, n(%) | 0.546 | |||
Female | 74 (41.1) | 50 (42.7) | 24 (38.1) | |
Male | 106 (58.9) | 67 (57.3) | 39 (61.9) | |
WBC, median(IQR)109/L | 11.95 (8.10, 16.47) | 11.20 (7.50, 16.10) | 13.00 (9.05, 18.70) | 0.058 |
NEU, median(IQR)109/L | 10.55 (6.57, 15.00) | 9.45 (6.20, 13.91) | 11.95 (8.03, 16.62) | 0.054 |
LYM, median(IQR)109/L | 0.70 (0.40, 1.00) | 0.70 (0.50, 1.00) | 0.50 (0.30, 0.90) | 0.003 |
CRP, median(IQR)mg/L | 94.30 (50.00, 203.40) | 91.75 (47.15, 195.57) | 134.80 (58.35, 217.89) | 0.258 |
PCT, median(IQR)ng/mL | 2.03 (0.33, 15.30) | 2.04 (0.26, 10.90) | 1.98 (0.84, 24.93) | 0.203 |
HF, n(%) | 0.112 | |||
No | 114 (63.3) | 79 (67.5) | 35 (55.6) | |
Yes | 66 (36.7) | 38 (32.5) | 28 (44.4) | |
CHD, n(%) | 0.021 | |||
No | 150 (83.3) | 103 (88.0) | 47 (74.6) | |
Yes | 30 (16.7) | 14 (12.0) | 16 (25.4) | |
RF, n(%) | 0.137 | |||
No | 124 (68.9) | 85 (72.7) | 39 (61.9) | |
Yes | 56 (31.1) | 32 (27.4) | 24 (38.1) | |
DM, n(%) | 0.125 | |||
No | 135 (75.0) | 92 (78.6) | 43 (68.3) | |
Yes | 45 (25.0) | 25 (21.4) | 20 (31.8) | |
Source of infection, n (%) | 0.443 | |||
Lung | 131(72.8) | 86 (73.5) | 45 (71.4) | |
Abdomen | 23 (12.8) | 12 (10.3) | 11 (17.5) | |
Urinary | 9 (5.0) | 6 (5.1) | 3 (4.8) | |
Other | 17 (9.4) | 13 (11.1) | 4 (6.4) | |
APACHE II score, median(IQR) | 17.0 (13.0, 22.0) | 14.0 (12.0, 19.0) | 22.0 (18.0, 26.0) | < 0.001 |
GCS score, median(IQR) | 11.5 (6.0, 15.0) | 12.0 (6.0, 15.0) | 8.0 (5.0, 12.5) | 0.003 |
SOFA score, median(IQR) | 6.0 (4.0, 8.0) | 5.0 (4.0, 7.0) | 7.0 (6.0, 11.0) | < 0.001 |
